Prev：Controllable mitochondrial aggregation and fusion by a programmable DNA binder(KTP4003-8.4)
Next：Diselenide‐Based Dual‐Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy(A23210-10)
